Registry for patients with heart conditions and treatments
Cardiology Research Dubrava: Single Centre, Prospective Registry
University Hospital Dubrava · NCT06090591
This study is collecting information from patients with heart conditions who have received certain treatments to see how they are doing over time and improve care for these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital Dubrava (other) |
| Locations | 1 site (Zagreb) |
| Trial ID | NCT06090591 on ClinicalTrials.gov |
What this trial studies
The Cardiology Research Dubrava registry is a prospective, single-center initiative that collects data from patients with various heart conditions, including acute coronary syndrome, heart failure, and atrial fibrillation. It focuses on patients who have received specific treatments such as SGLT-2 inhibitors, TAVI implantation, and anticoagulation therapy. The registry aims to monitor clinical status, laboratory results, bleeding complications, and major cardiovascular events over the long term. This comprehensive data collection will help improve understanding and management of these conditions.
Who should consider this trial
Good fit: Ideal candidates include patients with acute coronary syndrome, heart failure, atrial fibrillation, or those who have undergone specific cardiac interventions.
Not a fit: Patients who are non-compliant or not undergoing follow-up at the participating center may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance treatment strategies and outcomes for patients with heart conditions.
How similar studies have performed: Other similar registries have shown success in improving patient outcomes and understanding of cardiovascular diseases.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: patients implanted with CIED, or with VTE, or with ACS or with TAVI - Exclusion Criteria: non compliance, not undergoing follow-up at this center \-
Where this trial is running
Zagreb
- Dubrava University Hospital — Zagreb, Croatia (RECRUITING)
Study contacts
- Principal investigator: Irzal Hadzibegovic, M.D. — Dubrava University Hospital
- Study coordinator: Ivan Zeljkovic, M.D.
- Email: kardio@kbd.hr
- Phone: 00385917823289
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Heart Failure, Arrhythmias, Cardiac, Atrial Fibrillation, Acute Coronary Syndrome, chronic heart failure, acute coronary syndrome, SGLT-2 inhibitors, anticoagulants